Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

4.90
Delayed Data
As of 11:33am ET
 -0.05 / -1.01%
Today’s Change
2.00
Today|||52-Week Range
5.25
+63.33%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close4.95
Today’s open5.00
Day’s range4.90 - 5.00
Volume121,130
Average volume (3 months)452,751
Market cap$162.5M
Dividend yield--
Data as of 11:33am ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-21.65%
Earnings growth (this year)+46.82%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+6.28%
P/E ratioNM
Price/Sales1.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...+0.03+0.96%
TRVNTrevena Inc-0.02-0.80%
REPHRecro Pharma Inc+0.16+1.85%
MDWDMediwound Ltd0.000.00%
Data as of 11:33am ET, 09/22/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$54.4M
Annual profit (last year)-$19.6M
Net profit margin-35.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts